![Soliris Eculizumab 300mg at 44840.00 INR in Bengaluru, Karnataka | Kushal Hearth Care Medical Center Soliris Eculizumab 300mg at 44840.00 INR in Bengaluru, Karnataka | Kushal Hearth Care Medical Center](https://tiimg.tistatic.com/fp/1/006/948/soliris-eculizumab-300mg-049.jpg)
Soliris Eculizumab 300mg at 44840.00 INR in Bengaluru, Karnataka | Kushal Hearth Care Medical Center
![After discount, U.K. price watchdog gives a nod to Alexion's Ultomiris for a second rare blood disorder | Fierce Pharma After discount, U.K. price watchdog gives a nod to Alexion's Ultomiris for a second rare blood disorder | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621456453/Ultomiris.jpg/Ultomiris.jpg?VersionId=2LhQR4uL_8mEWTw_tbG.7boH7NBinikg)
After discount, U.K. price watchdog gives a nod to Alexion's Ultomiris for a second rare blood disorder | Fierce Pharma
![Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria | PharmacoEconomics Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria | PharmacoEconomics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40273-020-00929-z/MediaObjects/40273_2020_929_Fig2_HTML.png)
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria | PharmacoEconomics
What would be the cost of soliris (world's most expensive drug) after it goes off the patent in 2019? Present cost 500,000 $ per year. - Quora
![Soliris Eculizumab 300mg, 1 Vial Of 30 ml (10 mg/ml), Treatment: For Intravenous Use at Rs 155000/vial in Nagpur Soliris Eculizumab 300mg, 1 Vial Of 30 ml (10 mg/ml), Treatment: For Intravenous Use at Rs 155000/vial in Nagpur](http://5.imimg.com/data5/SELLER/Default/2023/10/355667244/NX/DS/BY/16645300/soliris-eculizumab-300mg-500x500.jpeg)
Soliris Eculizumab 300mg, 1 Vial Of 30 ml (10 mg/ml), Treatment: For Intravenous Use at Rs 155000/vial in Nagpur
![Hematology Reports | Free Full-Text | Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment Hematology Reports | Free Full-Text | Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment](https://www.mdpi.com/hematolrep/hematolrep-15-00060/article_deploy/html/images/hematolrep-15-00060-g001.png)